Tafasitamab (Anti-CD19)
A2563
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameTafasitamab (Anti-CD19)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionTafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkins lymphoma. MW:145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203